donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRNA Moderna > Detailed Quotes

MRNA Moderna

182.940
-3.900-2.09%
Close 08/08 16:00 ET
178.500
-4.44-2.43%
Post Mkt Price 08/08 18:26 ET
High
190.280
Open
185.200
Turnover
751.18M
Low
180.090
Pre Close
186.840
Volume
4.07M
Market Cap
71.57B
P/E(TTM)
5.57
52wk High
464.850
Shares
391.20M
P/E(Static)
6.47
52wk Low
115.610
Float Cap
65.84B
Bid/Ask %
42.86%
Historical High
497.490
Shs Float
359.91M
Volume Ratio
0.60
Historical Low
11.540
Dividend TTM
--
Div Yield TTM
150
P/B
3.98
Dividend LFY
--
Div Yield LFY
81.99%
Turnover Ratio
1.13%
Amplitude
5.45%
Avg Price
184.416
Lot Size
1
Float Cap
65.84B
Bid/Ask %
42.86%
Historical High
497.490
Shs Float
359.91M
Volume Ratio
0.60
Historical Low
11.540
Dividend TTM
--
P/B
3.98
Dividend LFY
--
Turnover Ratio
1.13%
Amplitude
5.45%
Avg Price
184.416
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
CEO: --
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...